Neuland Laboratories Q2 profit falls 46.7% as margins contract
In short
Neuland Laboratories reported Q2 results with consolidated profit down 46.7% to ₹51.6 crore. EBITDA margin also fell to 21.7% from 30.2% a year earlier.
The company said performance was weaker in the quarter. It still expects FY27 growth, but the reporting does not say what caused the drop.
What the reporting says
Neuland Laboratories reported a 46.7% year-on-year decline in consolidated profit to ₹51.6 crore in Q2, alongside an EBITDA margin drop to 21.7% from 30.2% a year earlier. The company said quarterly performance dipped, according to a publisher-supplied summary. The immediate effect is weaker earnings momentum, while the reporting does not explain the underlying driver of the fall or give full revenue details.
Why it matters
Neuland Laboratories reported a sharp fall in Q2 profitability, with consolidated profit down 46.7% year on year to ₹51.6 crore and EBITDA margin lower at 21.7%. The publisher-supplied summary says the company blamed a dip in quarterly performance and still kept its FY27 growth expectations. The reporting does not state the revenue number or the specific reason for weaker earnings.